BioCer HaemoCer™ Haemostatic Powder

País: Singapur

Idioma: inglés

Fuente: HSA (Health Sciences Authority)

Disponible desde:

NOVEM HEALTHCARE PTE LTD

clase:

Class D medical device

Fabricado por:

BioCer Entwicklungs-GmbH

Área terapéutica:

General & Plastic Surgery

indicaciones terapéuticas:

HaemoCer™ is an adjunct hemostatic agent for use in surgical procedures, when control of bleeding from capillary, venous, or arteriolar vessels by pressure, ligature and other conventional procedures is either ineffective or impractical.

Resumen del producto:

Device System Info:[System or Procedure Pack], [Sterile Medical Device], Radiation sterilisation for the haemostatic powder and EO sterilization for the applicator; Models: HaemoCer™ Haemostatic Powder (5g) - HFP105, HaemoCer™ Haemostatic Powder (2g) - HFP102, HaemoCer™ PLUS Haemostatic Powder 1g powder with applicator - HFP201, HaemoCer™ PLUS Haemostatic Powder 2g powder with applicator - HFP202, HaemoCer™ PLUS Haemostatic Powder 3g powder with applicator - HFP203, HaemoCer™ PLUS Haemostatic Powder 5g powder with applicator - HFP205, HaemoCer™ Universal Applicator - HFZ101

Fecha de autorización:

2013-05-23